Recce breathes better on positive lung infection drug pilot test results
Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MTE | new code? | 20/12/14 | 2 | 3.3K | |||
|
|||||||
MTE | Ann: Presentation to Gold Coast Investor Showcase | 02/12/14 | 0 | 985 | |||
|
|||||||
MTE | Ann: Initial Director's Interest Notice | 01/12/14 | 0 | 880 | |||
|
|||||||
MTE | Ann: Final Director's Interest Notice | 01/12/14 | 0 | 1.0K | |||
|
|||||||
MTE | Ann: Terms of Contract for new CEO | 28/11/14 | 0 | 1.0K | |||
|
|||||||
MTE | Ann: Results of 2014 AGM Meeting | 27/11/14 | 0 | 906 | |||
|
|||||||
MTE | Ann: Chief Executive Officer's 2014 AGM Address | 25/11/14 | 0 | 678 | |||
|
|||||||
MTE | Ann: 2014 Chairman's Address to Shareholders | 25/11/14 | 0 | 619 | |||
|
See All Discussions